Virpax Pharmaceuticals

Manufacturing · Pennsylvania, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1055 Westlakes Dr Ste 300, Berwyn, Penns...

Phone Number

(610) 727-4597

Revenue

<$5 Million

Stock Symbol

VRPX

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1

About Virpax Pharmaceuticals

Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval of its three patented drug delivery platforms. Epoladerm is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Probudur is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal Molecular-Envelope Technology (MET) enkephalin formulation being developed for the management post cancer pain and non-cancer pain, as well as post-traumatic stress disorder (PTSD) under the name PES200. MET technology is also used in AnQlar, a candidate to inhibit viral replication caused by influenza or SARS-CoV-2. Virpax recently acquired global rights to VRP324, a product candidate for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management ofRead more
Virpax Pharmaceuticals's Social MediaPopular SearchesVirpax Pharmaceuticals IncVirpax PharmaceuticalsVirpax Pharmaceuticals Engages Destum PartnersVirpax Pharmaceuticals Inc (Nasdaq:VRPX)SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: VRPXShow more

Virpax Pharmaceuticals Org Chart

Jatinder Dhaliwal, Chief Executive Officer & Interim Chief Financial Officer & Director at Virpax Pharmaceuticals
United States flag for contact location.

Chief Executive Officer & Interim Chief Finan...

PhoneEmail
SM
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AB
United States flag for contact location.

Software Engineer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Virpax Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Virpax Pharmaceuticals

Compare insights from companies similar to Virpax Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Virpax Pharmaceuticals

<$5M
1-10
Public
-
2017
Jatinder Dhaliwal, Chief Executive Officer & Interim Chief Financial Officer & Director at Virpax Pharmaceuticals
Jatinder DhaliwalCEO & Interim Chief Financial Officer & Director
$9.8M
11-50
Private
-
-
PZ
Paul ZimmermanChairman & CEO
$5M
51-200
Private
-
2017
N. Saxena, Chief Operations Officer at ACI Pharmaceuticals
N. SaxenaChief Operations Officer
<$5M
1-10
Private
-
-
LW
Lian WangVice President, Translational Sciences
<$5M
1-10
Private
$44.6M
2011
JM
Jeanne MclaughlinExecutive Assistant
<$5M
1-10
Private
-
2013
<$5M
1-10
Private
<$5M
2012
Crist Frangakis, President & Chief Executive Officer at Achelios Therapeutics
Crist FrangakisPresident & CEO
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Virpax Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Virpax Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Virpax Pharmaceuticals.

Virpax Pharmaceuticals Tech Stack

A closer look at the technologies used by Virpax Pharmaceuticals

Most Recent Scoops

Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Left Company
Executive Move
Executive Moves, Left Company
See more scoops

Top Manufacturing Companies

Frequently Asked Questions Regarding Virpax Pharmaceuticals

What is Virpax Pharmaceuticals's stock symbol?
Virpax Pharmaceuticals's stock symbol is VRPX
What is Virpax Pharmaceuticals's official website?
Virpax Pharmaceuticals's official website is www.virpaxpharma.com
What is Virpax Pharmaceuticals's Revenue?
Virpax Pharmaceuticals's revenue is <$5 Million
What is Virpax Pharmaceuticals's SIC code?
Virpax Pharmaceuticals's SIC: 28,283
What is Virpax Pharmaceuticals's NAICS code?
Virpax Pharmaceuticals's NAICS: 32,325
How many employees does Virpax Pharmaceuticals have?
Virpax Pharmaceuticals has 1-10 employees
What industry does Virpax Pharmaceuticals belong to?
Virpax Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Virpax Pharmaceuticals competition?
Virpax Pharmaceuticals top competitors include: SciFluor Life Sciences, ACI Pharmaceuticals, Amorsa Therapeutics, Pharmacin
What technology does Virpax Pharmaceuticals use?
Some of the popular technologies that Virpax Pharmaceuticals uses are: WordPress.org, PHP, Connectifier, LinkedIn Ads
Who is the CFO of Virpax Pharmaceuticals?
Virpax Pharmaceuticals's CFO is Jatinder Dhaliwal
How do I contact Virpax Pharmaceuticals?
Virpax Pharmaceuticals contact info: Phone number: (610) 727-4597 Website: www.virpaxpharma.com
What does Virpax Pharmaceuticals do?

Virpax is developing branded product candidates for non-addictive pain management and neurological disorders using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval of its three patented drug delivery platforms. Epoladerm is a topical diclofenac spray film formulation being developed to mana... ge osteoarthritis pain. Probudur is a single injection long-acting liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal Molecular-Envelope Technology (MET) enkephalin formulation being developed for the management post cancer pain and non-cancer pain, as well as post-traumatic stress disorder (PTSD) under the name PES200. MET technology is also used in AnQlar, a candidate to inhibit viral replication caused by influenza or SARS-CoV-2. Virpax recently acquired global rights to VRP324, a product candidate for the nasal delivery of a pharmaceutical-grade cannabidiol (CBD) for the management of rare pediatric epilepsy.Read More

What are Virpax Pharmaceuticals social media links?
Virpax Pharmaceuticals Linkedin page Virpax Pharmaceuticals Twitter page Virpax Pharmaceuticals Facebook page
Is Virpax Pharmaceuticals a public company?
Yes, Virpax Pharmaceuticals is a public company and is traded under the symbol VRPX
See more information about Virpax Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.